Amalgamated Bank Greenwich Life Sciences, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 207 shares of GLSI stock, worth $1,761. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207
Previous 207
-0.0%
Holding current value
$1,761
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GLSI
# of Institutions
49Shares Held
1.24MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$2.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA282KShares$2.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA139KShares$1.18 Million0.0% of portfolio
-
Credit Agricole S A87KShares$740,3700.0% of portfolio
-
Northern Trust Corp Chicago, IL82.8KShares$704,4490.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $109M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...